AU2003285281A8 - Topical application of curcumin for the treatment of peripheral neuropathy - Google Patents
Topical application of curcumin for the treatment of peripheral neuropathyInfo
- Publication number
- AU2003285281A8 AU2003285281A8 AU2003285281A AU2003285281A AU2003285281A8 AU 2003285281 A8 AU2003285281 A8 AU 2003285281A8 AU 2003285281 A AU2003285281 A AU 2003285281A AU 2003285281 A AU2003285281 A AU 2003285281A AU 2003285281 A8 AU2003285281 A8 AU 2003285281A8
- Authority
- AU
- Australia
- Prior art keywords
- curcumin
- treatment
- topical application
- peripheral neuropathy
- neuropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title 2
- 229940109262 curcumin Drugs 0.000 title 1
- 235000012754 curcumin Nutrition 0.000 title 1
- 239000004148 curcumin Substances 0.000 title 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title 1
- 208000033808 peripheral neuropathy Diseases 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EG2002111270 | 2002-11-25 | ||
| EG2002111270A EG23547A (en) | 2002-11-25 | 2002-11-25 | Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies |
| PCT/EG2003/000011 WO2004047717A2 (en) | 2002-11-25 | 2003-11-23 | Topical application of curcumin for the treatment of peripheral neuropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003285281A1 AU2003285281A1 (en) | 2004-06-18 |
| AU2003285281A8 true AU2003285281A8 (en) | 2004-06-18 |
Family
ID=32946815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003285281A Abandoned AU2003285281A1 (en) | 2002-11-25 | 2003-11-23 | Topical application of curcumin for the treatment of peripheral neuropathy |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003285281A1 (en) |
| EG (1) | EG23547A (en) |
| WO (1) | WO2004047717A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9393198B2 (en) | 2010-03-22 | 2016-07-19 | Signpath Pharma Inc. | Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| US20120237590A1 (en) * | 2011-03-16 | 2012-09-20 | Signpath Pharma Inc. | Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control |
| GB2507884B (en) | 2011-06-03 | 2019-10-23 | Signpath Pharma Inc | Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current |
| US10349884B2 (en) | 2011-06-03 | 2019-07-16 | Sighpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| US10238602B2 (en) | 2011-06-03 | 2019-03-26 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies |
| US12004868B2 (en) | 2011-06-03 | 2024-06-11 | Signpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel |
| US10449193B2 (en) | 2011-06-03 | 2019-10-22 | Signpath Pharma Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies |
| US10117881B2 (en) | 2011-06-03 | 2018-11-06 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies |
| AT515178A5 (en) | 2012-08-31 | 2015-07-15 | Univ North Texas | CURCUMIN-ER, A NANOCURCUMIN FROM LIPOSOMAL PLGA WITH CONTINUED RELEASE TO MINIMIZE QT EXTENSION TO CANCER THERAPY |
| CA2933204C (en) | 2013-12-18 | 2020-04-28 | Signpath Pharma, Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| US10413526B2 (en) | 2015-03-31 | 2019-09-17 | Kolinpharma S.P.A. | Composition for the treatment of neuropathies and/or neuropathic pain |
| US10668123B2 (en) | 2015-04-27 | 2020-06-02 | Omniactive Health Technologies Limited | Capsicum compositions and uses thereof |
| WO2017189424A2 (en) | 2016-04-27 | 2017-11-02 | Signpath Pharma, Inc. | Prevention of drug-induced atrio-ventricular block |
| IT201700088621A1 (en) * | 2017-08-01 | 2019-02-01 | Inpha Duemila Srl | Food supplements for use in the treatment of diseases associated with alterations of peripheral nerve trophism. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11246398A (en) * | 1998-03-02 | 1999-09-14 | Kyowa Hakko Kogyo Co Ltd | Agent for preventing or treating diseases caused by increased lipid peroxide in vivo |
| JPH11246399A (en) * | 1998-03-03 | 1999-09-14 | Lion Corp | Lipid metabolism improving composition |
-
2002
- 2002-11-25 EG EG2002111270A patent/EG23547A/en active
-
2003
- 2003-11-23 WO PCT/EG2003/000011 patent/WO2004047717A2/en not_active Ceased
- 2003-11-23 AU AU2003285281A patent/AU2003285281A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EG23547A (en) | 2006-05-10 |
| AU2003285281A1 (en) | 2004-06-18 |
| WO2004047717A3 (en) | 2004-09-23 |
| WO2004047717A2 (en) | 2004-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI345979B (en) | Topical pharmaceutical compositions for the treatment of dermatitis | |
| PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
| PL1620113T3 (en) | Topical formulation of ivermectin for the treatment of dermatological conditions | |
| ZA200507346B (en) | Topical formulation of ivermectin for the treatment of dermatological conditions | |
| EP1682136A4 (en) | Therapeutic compounds and uses thereof | |
| AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
| AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
| AU2003285281A8 (en) | Topical application of curcumin for the treatment of peripheral neuropathy | |
| EP1551388A4 (en) | Compounds useful for the treatment of cancer, compositions thereof and methods therewith | |
| AU2003251875A1 (en) | Combination therapy for the treatment of neoplasms | |
| TWI372047B (en) | Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same | |
| HUP0500199A3 (en) | Pharmaceutical composition comprising arsenite for the treatment of malignancy | |
| PT2845594T (en) | Use of dihydroimidazolones for the treatment of dogs | |
| AU2003258983A8 (en) | Combinations for the treatment of fungal infections | |
| GB0223650D0 (en) | Psoriasis treatment | |
| AU2003240174A1 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
| AU2003252187A8 (en) | Topical composition for the treatment of inflammatory conditions of the skin | |
| AU2003252701A1 (en) | Medicinal composition for treating thrombopenia | |
| AU2003227519A1 (en) | The use of milnacipran for the treatment of tension-type headache | |
| AU2003274067A1 (en) | Compounds for the treatment of cough | |
| HK1077495A (en) | Pharmaceutical composition comprising arsenite for the treatment of malignancy | |
| GB0229986D0 (en) | Treatment of materials | |
| HK1080458A (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
| AU2002950148A0 (en) | Pharmaceutical composition for the treatment of skin conditions | |
| ZA200410074B (en) | Topical composition for the treatment of inflammatory conditions of the skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |